In the last few weeks, I’ve given several presentations to European pharma companies about what kind of strategy they should endorse in order to use social media properly. And when it comes to regulations, we are all in trouble, because without exact answers, it’s hard to implement any kind of strategies. But now!
On November 12-13, the FDA will hold a hearing on how pharmaceutical companies use the web and social-media tools to market their products the first step to providing guidelines around this type of marketing. Sixty-two speakers from pharmaceutical companies, media companies, agencies, and others have been asked to give their viewpoints.
The reason why I’m writing about it is the perfect online coverage of the event. See FDASM for more details: